120 likes | 152 Views
Cancer is an abnormal growth of cells in the body, also known as malignancy. It has the potential to replicate itself rapidly and invade into other body parts also. There are numerous types of cancer present. Dendritic cells (part of neuron) plays an important role in inducing anti-tumor activity. Hence, various strategies are being developed to treat cancer with the help of dendritic cell. For generation of dendritic vaccine, dendritic cells are cultured alongside the cancer cells. The vaccine, when induced into body stimulates the immune system to attack cancer cells.
E N D
Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker
DENDRITIC CELL & TUMOR CELL CANCER VACCINES MARKET Cancer is an abnormal growth of cells in the body, also known as malignancy. It has the potential to replicate itself rapidly and invade into other body parts also. There are numerous types of cancer present. Dendritic cells (part of neuron) plays an important role in inducing anti-tumor activity. Hence, various strategies are being developed to treat cancer with the help of dendritic cell. For generation of dendritic vaccine, dendritic cells are cultured alongside the cancer cells. The vaccine, when induced into body stimulates the immune system to attack cancer cells.
Global Dendritic Cell and Tumor Cell Vaccines Market Drivers Increase in research and development activities related to dendritic cell and tumor cell based vaccines are expected to accelerate the global dendritic cell and tumor cell vaccines market growth. For instance, in March 2015, Rockefeller University and Memorial Sloan Kettering Cancer Center conducted a phase II study of autologous dendritic cell vaccines (DC/PC3). It is being used as an immunotherapy in the prostate cancer. The vaccine was developed by patient’s own cells. Furthermore, in April 2016, IstitutoScientificoRomagnolo per lo Studio e la CuradeiTumori (I.R.S.T.) S.r.l., began its study on autologous dendritic cells loaded with autologous tumor homogenate in combination with the drug IL-2. It is being used for the treatment of patients with stage IV colorectal cancer. The purpose of study is to evaluate the consistency of the response of immune cells after completion of the treatment. Currently, the study is in its second phase of clinical trials. Hence, such research and development activities of dendritic cell and tumor cell vaccines are expected to impel the global dendritic cell and tumor cell vaccines market growth.
Global Dendritic Cell and Tumor Cell Vaccines Market Regional Analysis North America is expected to be a dominant region in the global dendritic cell and tumor cell vaccines market, with increasing prevalence of cancer in the region. According to National Institutes of Health (NIH) data, in 2018, around 609,640 people died due to cancer and incidence rate was 439.2 per 100,000 men and women per year. The most occurring cancer type are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, and kidney and renal pelvis cancer. Hence, the higher prevalence of cancer may lead to higher demand for dendritic cell and tumor cell vaccines and thereby, expected to propel the global dendritic cell and tumor cell vaccine market growth.
Global Dendritic Cell and Tumor Cell Vaccines Market Restraints Withdrawal of dendritic cell and tumor cell vaccines from its clinical trials are expected to hamper the global dendritic cell and tumor cell vaccines clinical progress. For instance, in March 2016, IstitutoScientificoRomagnolo per lo Studio e la curadeiTumori, conducted its clinical trial for dendritic cell vaccine with radiotherapy. It was being studied for the treatment of renal cancer. However, it got withdrawn in its second phase of clinical trial (reason unspecified). Hence, this factor may have a negative impact on the global dendritic and tumor cell vaccine market growth. Global Dendritic Cell and Tumor Cell Vaccines Market Key Players Some of the major players operating in the global dendritic cell and tumor cell vaccines market include, JW CreaGene, MiltenyiBiotec, GlaxoSmithKline plc, NorthWestBioTherapeutics, ImmunoCellular Therapeutics, Ltd., EnoChian Biosciences, Medigene AG, DC Prime, Tella Incorporation, and CiMaas
Global Dendritic Cell and Tumor Cell Vaccines Market Taxonomy • By Antigen • CD 4 • CD 8 • HER-2 • T-helper cell • Others • By Application • Glioblastoma Cancer • Prostate Cancer • Pancreatic Cancer • Colorectal Cancer • Renal Cancer • Lung Cancer • Others
By Distribution Channel • Hospital pharmacies • Retail pharmacies • Online pharmacies • By Region • North America • Latin America • Europe • Asia Pacific • Middle East • Africa
About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs
Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/